IO Biotech Revenue and Competitors
Estimated Revenue & Valuation
- IO Biotech's estimated annual revenue is currently $7.4M per year.
- IO Biotech's estimated revenue per employee is $80,870
- IO Biotech's current valuation is $219M. (January 2022)
Employee Data
- IO Biotech has 92 Employees.
- IO Biotech grew their employee count by 14% last year.
IO Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Founder | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | SVP Clinical Development and Medical Affairs | Reveal Email/Phone |
5 | SVP, Regulatory Affairs | Reveal Email/Phone |
6 | Director, Head Information Technology | Reveal Email/Phone |
7 | Director Investor Relations & Corporate Communications | Reveal Email/Phone |
8 | Director Clinical Operations | Reveal Email/Phone |
9 | Senior Director Analytical Development and Peptide Chemistry | Reveal Email/Phone |
10 | Senior Director Clinical Operations | Reveal Email/Phone |
IO Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 15 | -29% | N/A | N/A |
#2 | $4096.4M | 10837 | 2% | N/A | N/A |
What Is IO Biotech?
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has two lead immune modulating anti-cancer therapies targeting IDO and PD-L1 in clinical development and several compounds finalizing preclinical phase. IO Biotech has an experienced management team within immuno-oncology fields and a world-class advisory board.
keywords:N/A
N/A
Total Funding
92
Number of Employees
$7.4M
Revenue (est)
14%
Employee Growth %
$219M
Valuation
N/A
Accelerator
IO Biotech News
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology...
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology...
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology...
Other Companies in Copenhagen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 92 | 5% | N/A |
#2 | $13.9M | 92 | 0% | N/A |
#3 | $8.6M | 93 | 43% | N/A |
#4 | $23.6M | 94 | 25% | N/A |
#5 | $13.6M | 94 | 65% | N/A |